课题基金 / 基金详情

Targeting atherosclerosis progression following pneumonia through pulmonary delivery of omega-3 fatty acids in nanoparticle carriers

Targeting atherosclerosis progression following pneumonia through pulmonary delivery of omega-3 fatty acids in nanoparticle carriers
通过纳米颗粒载体中的 omega-3 脂肪酸肺部递送来靶向肺炎后动脉粥样硬化的进展
批准号:
476336
负责人:
Stotts Cameron
金额:
$7.65万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-11-01 至 2025-11-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cardiovascular disease is the second leading cause of death in Canada. Atherosclerosis, a type of cardiovascular disease, is caused by the build-up of fats in the blood vessels. In an attempt to remove the fat, immune cells are recruited through a process
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金